Nuclear Imaging Devices And Equipment Global Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the global nuclear imaging devices and equipment market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the nuclear imaging devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Nuclear Imaging Devices And Equipment Market Global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery
- Market segmentations break down market into sub markets
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
Scope
Markets Covered:
1) By product type: SPECT systems; PET systems; Planar Scintigraphy;
2) By application: Oncology; Cardiology; Neurology; Other Applications (Orthopedics; Urology; Thyroid-related Disorders; and Gastroenterology)
3) By end user: Hospitals; Imaging Centers; Academic & Research Institutes; Other End Users (Pharmaceutical/Biotechnology Companies and CROs)
Companies Mentioned: Toshiba Medical Systems Corporation; Neusoft Medical Systems; SurgicEye GmbH; Siemens Healthineers; GE Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
This product will be delivered within 1-3 business days.
What is the estimated value of the Global Nuclear Imaging Devices and Equipment Market?
What is the growth rate of the Global Nuclear Imaging Devices and Equipment Market?
What is the forecasted size of the Global Nuclear Imaging Devices and Equipment Market?
Who are the key companies in the Global Nuclear Imaging Devices and Equipment Market?
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | May 2022 |
Forecast Period | 2022 - 2026 |
Estimated Market Value ( USD | $ 4.02 billion |
Forecasted Market Value ( USD | $ 5.15 billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |
Table of Contents
Executive Summary
Major players in the market are Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., SurgicEye GmbH, Siemens Healthineers, GE Healthcare, Mediso Medical Imaging Systems Ltd., Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, and Philips Healthcare.The global nuclear imaging devices and equipment market is expected to grow from $3.74 billion in 2021 to $4.02 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%. The market is expected to grow to $5.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%.
The nuclear imaging devices and equipment market consist of sales of nuclear imaging devices and related services. Nuclear imaging devices and equipment are used in the diagnosis of radioactive substances in patients.
The main product types in the nuclear imaging devices and equipment are SPECT systems, PET systems, and planar scintigraphy. The SPECT scan is used to capture the images and create 3D scanning. These are used for various applications such as oncology, cardiology, neurology, other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology that are used in hospitals, imaging centers, academic & research institutes, other end users (pharmaceutical/biotechnology companies and CROs).
Western Europe was the largest region in nuclear imaging devices and equipment market in 2021. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The nuclear imaging devices and equipment market is being driven by increasing incidences and prevalence of diseases such as cancer, heart disease, gastrointestinal, endocrine, and neurological disorders. Such diseases are diagnosed in relatively early stages by nuclear imaging equipment as compared to other equipment. For instance, according to the American Cancer Society 2020, in the United States, 1.8 million new cancer cases are diagnosed and 606,520 cancer deaths in the United States, many of which have been diagnosed by nuclear imaging devices and equipment.
The nuclear imaging devices and equipment market is being restrained by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC requires nuclear imaging equipment licensees to use and store radioactive materials to protect workers and common people by removing unwanted exposure, which has resulted in a relatively less number of nuclear imaging equipment being manufactured.
Companies in the nuclear imaging devices and equipment market are using hybrid imaging technologies such as positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI)
for nuclear medical imaging. These hybrid systems provide precise images with better resolution and both morphological and physiological information in just one instance of testing. For instance, a SPECT/CT system for skeletal evaluation offers accurate localization and improves the specificity of information provided by CT.
The Nuclear Regulatory Commission (NRC), USA regulates the manufacture and use of radioactive materials in nuclear imaging devices, as well as radiation therapy and research. It has agreements with 37 US states which allows them to regulate the use of certain radioactive materials by giving licenses to hospitals, clinics, and medical centers. The US-based Food and Drug Administration (FDA) also regulates products and procedures that are radiation-emitting. It reviews the safety and use of radiopharmaceuticals and machines like x-rays, which produce radiation but do not make or use radioactive material.
In April 2020, TTG Imaging Solutions, LLC, a company operating in nuclear medicine equipment based in the United States acquired Nuclear Imaging Services and Molecular Imaging Specialists for an undisclosed amount. With this acquisition, The company wants to expand its portfolio in diagnostics imaging. Nuclear Imaging Services is a company operating in nuclear imaging based in texas and Molecular Imaging Specialists, a company operating in nuclear imaging devices and equipment based in the United States.
The countries covered in the nuclear imaging devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Toshiba Medical Systems Corporation
- Neusoft Medical Systems Co. Ltd.
- SurgicEye GmbH
- Siemens Healthineers
- GE Healthcare
- Mediso Medical Imaging Systems Ltd.
- Digirad Corporation
- CMR Naviscan Corporation
- DDD Diagnostics
- Philips Healthcare
- Koninklijke Philips
- Fujifilm
- Carestream Health
- Shimadzu
- Canon inc.
- GVI Medical Devices
- Nucare Medical System
- Neurologica
- Positron Corporation
- AGFA Healthcare
- Hologic Inc.
- Shenzhen Mindray Bio-Medical EleCTronics Co. ltd.
- Samsung Medison
Methodology
LOADING...